PATENT ROBERT C 4
Research Summary
AI-generated summary
Metropolitan Bank (MCB) Director Robert C. Patent Sells Shares
What Happened Robert C. Patent, a director of Metropolitan Bank Holding Corp. (MCB), reported multiple open-market disposals on January 22–23, 2026, selling a total of 14,445 shares for aggregate proceeds of approximately $1,360,130. Individual sales included blocks of 4,998; 4,588; 414; 912; 1,433; and 2,100 shares at weighted-average prices in the mid-$90s (see Key Details). In addition, he was reported as acquiring 2,500 shares (awarded/restricted stock units) at no cash cost.
These transactions are primarily sales (often routine for insiders to diversify or satisfy tax/liquidity needs); the acquisition was an award/RSU grant rather than a market purchase.
Key Details
- Dates: Sales on 2026-01-22 and 2026-01-23; award reported 2026-01-23.
- Sales detail (weighted avg. prices and noted ranges per filing footnotes):
- 4,998 shares — $94.64 (weighted; trades ranged ~$94.00–$95.00). (F1)
- 4,588 shares — $95.28 (weighted; trades ranged ~$95.01–$95.54). (F3)
- 414 shares — $96.16 (weighted; trades ranged ~$96.03–$96.32). (F4)
- 912 shares — $90.04 (single-weight price reported).
- 1,433 shares — $92.14 (weighted; trades ranged ~$92.00–$92.2866). (F5)
- 2,100 shares — $93.36 (weighted; trades ranged ~$93.177–$93.522). (F6)
- Total sold: 14,445 shares for ~$1,360,130; Total acquired by award: 2,500 shares (no cash).
- Vesting/award notes: Footnotes indicate restricted stock units with vesting dates noted (some vest 100% on Jan 27, 2026; others vest 100% on Jan 23, 2027). (F2, F7)
- Filing timeliness: Report filed 2026-01-26 for transactions on 2026-01-22 and 01-23 — the filing appears timely per standard Form 4 rules. No 10b5-1 plan or late filing is disclosed in the provided excerpt.
- Shares owned after the transactions: Not specified in the excerpt provided.
Context
- Sales by directors are common and do not necessarily signal company outlook; purchases (or retention of shares) tend to be more informative about insider bullishness.
- The reported acquisition is an award/RSU grant (vesting schedule noted in footnotes), not an open-market buy.
- Weighted-average prices and ranges mean each reported block was executed in multiple trades at varying prices; full per-trade detail is available from the filer upon request, per the footnotes.